找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: HDL Deficiency and Atherosclerosis; G. Assmann Book 1995 Kluwer Academic Publishers 1995 Lipoprotein.atherosclerosis.cardiovascular.corona

[復(fù)制鏈接]
樓主: 宣告無效
21#
發(fā)表于 2025-3-25 03:52:23 | 只看該作者
22#
發(fā)表于 2025-3-25 09:33:50 | 只看該作者
Connection between cholesterol efflux and atherosclerosis, The two major subclasses include particles that contain both apoA-I and apoA-II (termed LpA-I, A-II) and those that contain apoA-I but not apoA-II (termed LpA-I). Apo-specific particles can be isolated by use of immunoaffinity columns with anti-apoA-I or anti-apoA-II antibody..
23#
發(fā)表于 2025-3-25 14:06:19 | 只看該作者
https://doi.org/10.1057/9781137295866 possesses arginine. The apoE2 isoform, associated with type III hyperlipoproteinaemia., differs from apoE3 only at residue 158, where it possesses cysteine. Apolipoproteins E3 and E4 bind normally to the low density lipoprotein (LDL) receptor, whereas apoE2 does not.
24#
發(fā)表于 2025-3-25 15:50:58 | 只看該作者
25#
發(fā)表于 2025-3-25 23:18:23 | 只看該作者
Book 1995on of massive scientific research, continuous transfer of the results to medical practice, community actions and population aware- ness. The death rate from coronary heart disease in the United States rose 20% from 1950 to 1963, when a dramatic and steady downward inflection began, arriving today at
26#
發(fā)表于 2025-3-26 01:16:32 | 只看該作者
HDLC as a therapeutic target in coronary disease: current concepts and future directions,support the concepts that HDL-related measures are as important as LDL-related ones in predicting vascular events. Furthermore, pharmacological or genetic modification of certain plasma HDL subfractions appears to hold promise for clinical benefits that are comparable to, or perhaps exceed, those of LDLC reduction.
27#
發(fā)表于 2025-3-26 05:08:55 | 只看該作者
28#
發(fā)表于 2025-3-26 09:51:21 | 只看該作者
HDL Deficiency and Atherosclerosis978-94-011-6585-3Series ISSN 0166-9842
29#
發(fā)表于 2025-3-26 13:04:37 | 只看該作者
30#
發(fā)表于 2025-3-26 17:31:39 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-12 21:35
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
布拖县| 西平县| 平阳县| 阿荣旗| 昭苏县| 营口市| 中卫市| 大足县| 萍乡市| 新巴尔虎右旗| 林周县| 高邮市| 普陀区| 西畴县| 太仓市| 岳普湖县| 莫力| 汉川市| 乐东| 宜都市| 平山县| 宁远县| 清水河县| 昂仁县| 额济纳旗| 和田县| 合山市| 清水县| 曲阜市| 高碑店市| 营山县| 亚东县| 重庆市| 青海省| 盐亭县| 晴隆县| 子长县| 皋兰县| 辛集市| 鞍山市| 徐州市|